3.1.6. TMEM106B Protein Levels Are Elevated in Individuals Affected with Mild Cognitive Impairment and Alzheimer’s Disease Compared to Cognitively Unimpaired Individuals. This evidence concerns the gene TMEM106B and Cognitive impairment.